Dr. Rana R. McKay Mourad MD is an Associate Professor of Medicine at the University of California San Diego and Co-Leader of the Genitourinary Oncology Disease Team at the Moores Cancer Center. She is a board-certified medical oncologist who specializes in treating people with urogenital cancers, including bladder, kidney, prostate, and testicular cancer. Her research interests include the design and implementation of clinical trials to advance the treatment of patients with urologic cancers. She serves as the Principal Investigator of several early phase trials in kidney and prostate cancer. As a clinical investigator, she is committed to advancements that will improve the lives of individuals with cancer. Furthermore, she is interested in understanding mechanisms of response and resistance to specific cancer therapies. Her work has appeared in peer-reviewed publications such as the Nature, Lancet, Journal of Clinical Oncology, Clinical Cancer Research, Cancer, among others. Dr. McKay earned her medical degree at the University of Florida College of Medicine before completing her residency in Internal Medicine at Johns Hopkins Hospital. She completed a fellowship in Oncology/Hematology at the Dana-Farber Cancer Institute, Harvard Medical School. She went on to serve as an Assistant Professor at Harvard Medical School and a medical oncologist at Dana-Farber/Brigham and Women's Cancer Center in Boston before joining UC San Diego Health..
Dr. Sébastien J. Hotte, M.D., MSc (HRM), FRCPC. did his undergraduate training and went on to qualify as a physician at the University of Ottawa in 1996. He pursued internal medicine at the University of Western Ontario in London, Canada and became a fellow of the Royal College of Physicians of Canada in 2000. His subspecialty training was in Medical Oncology at Western and he received his certificate of special competence in 2001. From 2001 to 2003, Dr. Hotte completed a clinical research fellowship in Developmental Therapeutics at the Juravinski Cancer Centre and obtained a Master’s Degree in Health Research Methodology from McMaster University. Dr. Hotte is currently an Associate Professor in the Department of Oncology of McMaster University and is a staff oncologist at the Juravinski Cancer Centre. He is the Chair of Department of Oncology Fellowship Program and the medical oncology fellowship director. His main clinical and research interests are in genito-urinary malignancies and he serves as co-chair of the GU disease site group of the Cancer Care Ontario Program for Evidence Based Care (CCO-PEBC) and has recently been named as Chair of the GU Disease Site Team of the Canadian Cancer Trials Group (CCTG) and a member of the National Cancer Institute (US) GU trials Steering Committee. Other research interests include Developmental Therapeutics and Phase I trials and he is currently the Head of the Phase I Program at the Juravinski Cancer Centre. Lastly, he is active in the field of translational research and has been appointed as a Scientist of the Escarpment Cancer Research Institute and is known nationally for clinical and research expertise in malignancies of the head and neck and thyroid. He is the principle or co-author of over 130 peer-reviewed articles and over 200 original research abstracts and a regular reviewer for multiple journals and grant panels. First and foremost, however, he is a husband and the proud father of two exceptional children, as well as a road cycling weekend warrior and Zwift afficionado. .
For more information, please send requests to Robyn Leonard at email@example.com.